Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use.
about
Making inroads into improving treatment of bacterial vaginosis - striving for long-term cureResearch gaps in defining the biological link between HIV risk and hormonal contraceptionThe complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota.Prevalent and incident bacterial vaginosis are associated with sexual and contraceptive behaviours in young Australian women.A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.Factors Associated with Symptomatic Vulvovaginal Candidiasis: A Study among Women Attending a Primary Healthcare Clinic in Kwazulu-Natal, South Africa.Sexually transmitted diseases treatment guidelines, 2015.Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysisLongitudinal analysis of vaginal microbiome dynamics in women with recurrent bacterial vaginosis: recognition of the conversion process.Diagnosis of bacterial vaginosis by a new multiplex peptide nucleic acid fluorescence in situ hybridization method.Molecular analysis of the relationship between specific vaginal bacteria and bacterial vaginosis metronidazole therapy failure.Normal flora and bacterial vaginosis in pregnancy: an overview.Diagnostic Value of Vaginal Discharge, Wet Mount and Vaginal pH - An Update on the Basics of Gynecologic InfectiologyCervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tractPenile Microbiota and Female Partner Bacterial Vaginosis in Rakai, UgandaA Study of the Vaginal Microbiome in Healthy Canadian Women Utilizing cpn60-Based Molecular Profiling Reveals Distinct Gardnerella Subgroup Community State Types.Women's Views and Experiences of the Triggers for Onset of Bacterial Vaginosis and Exacerbating Factors Associated with Recurrence.Women view key sexual behaviours as the trigger for the onset and recurrence of bacterial vaginosis.Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.Recent Biomarker-Confirmed Unprotected Vaginal Sex, But Not Self-reported Unprotected Sex, Is Associated With Recurrent Bacterial Vaginosis.Benzoyl peroxide formulated polycarbophil/carbopol 934P hydrogel with selective antimicrobial activity, potentially beneficial for treatment and prevention of bacterial vaginosis.Metronidazole for the treatment of vaginal infections.The Vaginal Microbiome: Current Understanding and Future Directions.Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation.Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract.Correlates of Bacterial Vaginosis Over Long-Term Follow-Up: Impact of HIV Infection.The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), ε-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis.Incident bacterial vaginosis (BV) in women who have sex with women is associated with behaviors that suggest sexual transmission of BV.Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples - A pilot study.Two Phase 1, Open-Label, Single-Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions.The influence of behaviors and relationships on the vaginal microbiota of women and their female partners: the WOW Health Study.Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense.
P2860
Q26798310-4E066E77-5BE3-4415-8E66-A86913D10BEDQ27002559-2A870CF2-7415-4D70-BB17-A23EBC833398Q27692596-FE75BA73-00D4-47D5-97A4-806FD9306B23Q31112477-EEDC6984-96B4-4290-94E8-EC5E2F25FDF4Q33763511-D5BCB9C7-9D27-4DDD-8D6E-5E3A5D52A38DQ33809541-52C0BE74-7F53-427B-8F54-2D574E2192A9Q34479272-1A2E67A5-8E51-4EDF-A814-88F314CB0D84Q34984200-2A92EE1F-7897-41C0-A7F2-803C7BF53372Q35077640-9E519944-A28C-48DB-B3E9-4AB7B5461EE0Q35115238-0F0554E0-C7A5-4497-B557-58D68A72E8E3Q35166565-3E29724D-13C5-45D6-AC6F-1A1994D98E94Q35592893-E5AA3654-73CA-405B-9FFF-DD35D30322E2Q35624659-44DC796A-5F6C-463C-A244-08137C5CBC6BQ35636288-4B7A4AB6-F661-4DA3-9BA5-F0F0E6D188C3Q35665408-C8D876DE-AD16-4FDC-B5C7-19D95C811321Q35743671-EC374C0D-0C76-4955-8F15-6878C556F2DFQ35941094-EBA74CA1-1C46-4039-8A22-BC42C24B4D7AQ36302752-BD344A51-FFD6-4ADF-BCF9-7770EEFCDEFBQ36460017-70E8DF2D-12DC-49DB-899A-17F4EAFC461EQ36567255-7D45E932-2B2A-4BA9-9FF1-AF9A14B402EDQ37409106-0FDD2BB3-0DD8-440B-80B9-A98D2626887BQ38426732-BA6BF6A6-E002-4672-B88A-D749B6059EDBQ38838623-3DB93FD2-1F60-47E0-A425-631A021E47E2Q38838626-A288A6EC-259A-462D-BE01-0066B48A67D5Q39135146-CCC3A727-7683-461E-9251-B0C8164D4011Q40047233-6F6776D7-7F89-4ABD-B21F-A3AD263B6968Q40453251-8EBDF54D-97DD-48EC-BA7A-D53A64BD388CQ41544969-518E2983-4CC2-45D4-BD5F-7FFB4C83596FQ41681149-64D754CE-BD49-4908-9BB3-2F57A649A0ADQ47224024-9883CF80-18BF-4521-BE2E-16C030534DE9Q47583539-0B95238D-4868-448E-A3C7-D8CEE624B690Q51181629-B4DAEA17-9E42-4D59-968C-F714DF9F6752Q51739532-71D3AF9D-F012-4F1D-A2D5-5EC21885B982
P2860
Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Recurrence of bacterial vagino ...... nd hormonal contraceptive use.
@ast
Recurrence of bacterial vagino ...... nd hormonal contraceptive use.
@en
Recurrence of bacterial vagino ...... nd hormonal contraceptive use.
@nl
type
label
Recurrence of bacterial vagino ...... nd hormonal contraceptive use.
@ast
Recurrence of bacterial vagino ...... nd hormonal contraceptive use.
@en
Recurrence of bacterial vagino ...... nd hormonal contraceptive use.
@nl
prefLabel
Recurrence of bacterial vagino ...... nd hormonal contraceptive use.
@ast
Recurrence of bacterial vagino ...... nd hormonal contraceptive use.
@en
Recurrence of bacterial vagino ...... nd hormonal contraceptive use.
@nl
P2093
P2860
P50
P356
P1476
Recurrence of bacterial vagino ...... nd hormonal contraceptive use.
@en
P2093
Anna N Morton
Deborah De Guingand
Marie Pirotta
Suzanne M Garland
P2860
P304
P356
10.1093/CID/CIS1030
P407
P577
2012-12-12T00:00:00Z